(Q44449930)

3 December 2017

title

ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma (English)

1 reference

3 December 2017

author

Noppadol Larbcharoensub

2

object named as

Noppadol Larbcharoensub

0 references

author name string

Warut Tulalamba

1

1 reference

3 December 2017

Noppadol Larbcharoensub

2

1 reference

3 December 2017

Tavan Janvilisri

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

13 May 2014

1 reference

Journal of Clinical Pathology

3 December 2017

published in

1 reference

3 December 2017

volume

67

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

667-672

1 reference

ErbB receptors: directing key signaling networks throughout life

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

ErbB receptors and signaling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Epidermal growth factor receptor biology in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The status and role of ErbB receptors in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The enigmatic epidemiology of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Adhesion molecules as prognostic factors in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression of HER2 and C-KIT in Nasopharyngeal Carcinoma: Implications for a New Therapeutic Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The N-terminal domain of EBNA1 acts as a suppressor of the HER2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression of c-erbB3 protein in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

c-erbB3 protein expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

ErbB-3 predicts survival in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Regulation of cyclooxygenase-2 pathway by HER2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

The ERBB3 receptor in cancer and cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

Expression and Nuclear Localization of ErbB3 in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-202154

10.1136/JCLINPATH-2013-202154

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference